Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Smart Inhalers Market Size Changed, over the years?
The market size of smart inhalers has seen significant growth in recent years. The prediction shows a rise from $1.65 billion in 2024 to $1.81 billion in 2025, implying a compound annual growth rate (CAGR) of 10.1%. Stakeholders can attribute the expansion in the historic period to better patient adherence to medical instructions, an increased emphasis on patient-centered healthcare, and a mounting call for connected healthcare devices.
How Much Will the Smart Inhalers Market Be Worth in 2029?
In the coming years, the market size for smart inhalers is predicted to experience a significant increase, with its value anticipated to reach $2.66 billion in 2029, marking a compound annual growth rate (CAGR) of 10.1%. The escalation during the forecast period is likely due to the increasing cases of chronic respiratory diseases (CRDs), the heightened need for home healthcare, and a surge in the acceptance of digital healthcare solutions. Noteworthy trends expected within the forecast period involve the technological evolution of smart inhalers, big data analytics, the application of chip-on-sensors, and advancements in sensor technology.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14196&type=smp
Which is the Largest Company in the Smart Inhalers Market?
Major companies operating in the smart inhalers market are Novartis AG, AstraZeneca Plc, GlaxoSmithKline Plc., 3M Health Care Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Group Inc., Aptar Group Inc., Lupin Limited, Findair Sp.Z.o.o., OPKO Health Inc., Nemera France SAS, Vectura Group Limited, Propeller Health, Inspiro Medical Ltd., Biocorp Production, Cohero Health Inc., Pneuma Respiratory Inc., Amiko Digital Health Limited, Cognita Labs LLC, AireHealth Inc., Adherium Ltd., Zeolr Technologies Pvt Ltd., H&T Presspart Manufacturing Ltd.
What Are the Main Market Drivers in the Smart Inhalers Industry?
The smart inhaler market is predicted to grow due to the increasing incidence of chronic respiratory diseases (CRDs). CRDs encompass a variety of persistent conditions which affect the lungs and the airways. Through usage tracking and reminding users of neglected doses, smart inhalers can assist in managing chronic respiratory conditions like asthma and COPD, guaranteeing regular medication use for symptoms control and prevention of exacerbation. For instance, the 2022 National Health Survey by the Australian Bureau of Statistics reports that roughly 8.5 million Australians, representing 34% of the populace, are afflicted by chronic respiratory conditions. Among them, approximately 2.8 million (11%) suffer from asthma, marked by wheezing and breath shortness due to inflammation of the airways. Moreover, an estimate reveals that around 638,000 persons (or 2.5%) are believed to have chronic obstructive pulmonary disease (COPD), characterized by enduring airflow obstruction that can lead to severe difficulties in breathing. Both conditions pose a significant health risk, impairing daily activities and the overall quality of life. Hence, the escalating prevalence of chronic respiratory diseases (CRDs) is propelling the expansion of the smart inhaler market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=14196&type=smp
How Is the Smart Inhalers Market Segments Structured?
The smart inhalers market covered in this report is segmented –
1) By Type: Dry Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs)
2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By End-User: Hospitals, Homecare Settings, Other End-Users
Subsegments:
1) By Dry Powdered Inhalers (DPIs): Single-Dose DPIs, Multi-Dose DPIs
2) By Metered Dose Inhalers (MDIs): Conventional MDIs, Smart MDIs With Connectivity Features
What Strategic Trends Are Transforming the Smart Inhalers Market?
Key players in the smart inhaler market are focusing on the creation of new technologies, specifically digital respiratory health solutions, to expand their customer reach, boost sales, and augment revenue. A digital respiratory health solution encompasses tech-driven interventions or platforms that help address and manage respiratory health problems. In this context, Aptar Pharma, a pharmaceutical services company from the United States, in February 2022, announced the launch of HeroTracker Sense. This is a unique digital respiratory health solution which acts as a connected add-on device that transforms regular metered-dose inhalers (MDIs) into intelligent connected healthcare tools. The device is uniquely designed for patients suffering globally from chronic respiratory diseases, including asthma, COPD, cystic fibrosis, and conditions related to COVID-19. The aim of this advanced MDI add-on device is to improve patient lifestyle. The HeroTracker Sense, when attached to an MDI canister, introduces sophisticated features such as sensors that monitor inhalation coordination, flow speed, and duration. It makes available data through a related app, providing timestamps for medicine reminders and warnings for environmental changes like temperature and humidity variations. The objective of the device is to promote patient compliance with prescribed treatments by facilitating knowledgeable and proper medication intake.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/smart-inhalers-global-market-report
Which Global Regions Offer the Highest Growth in the Smart Inhalers Market?
North America was the largest region in the smart inhalers market in 2024. The regions covered in the smart inhalers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14196
This Report Delivers Insight On:
1. How big is the smart inhalers market, and how is it changing globally?
2. Who are the major companies in the smart inhalers market, and how are they performing?
3. What are the key opportunities and risks in the smart inhalers market right now?
4. Which products or customer segments are growing the most in the smart inhalers market?
5. What factors are helping or slowing down the growth of the smart inhalers market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model